EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical features of prostate cancer by polygenic risk score

Christina Spears iD, Menglin Xu iD, Abigail Shoben, Shawn Dason, Amanda Ewart Toland iD, Lindsey Byrne

Familial Cancer · 2024

DOI: 10.1007/s10689-024-00369-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, 2024. Verfasst von Christina Spears und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University, 2012 Kenny Road, Columbus, OH, 43212, US…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Genome-Wide Association Study, Multifactorial Inheritance, Genetic Predisposition to Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide association studies have identified more than 290 single nucleotide variants (SNVs) associated with prostate cancer. These SNVs can be combined to generate a Polygenic Risk Score (PRS), which estimates an individual’s risk to develop prostate cancer. Identifying individuals at higher risk for prostate cancer using PRS could allow for personalized screening recommendations, improve current screening tools, and potentially result in improved survival rates, but more research is needed before incorporating them into clinical use. Our study aimed to investigate associations between PRS and clinical factors in affected individuals, including age of diagnosis, metastases, histology, International Society of Urological Pathology (ISUP) Grade Group (GG) and family history of prostate cancer, while taking into account germline genetic testing in known prostate cancer related genes. To evaluate the relationship between these clinical factors and PRS, a quantitative retrospective chart review of 250 individuals of European ancestry diagnosed with prostate cancer who received genetic counseling services at The Ohio State University’s Genitourinary Cancer Genetics Clinic and a 72-SNV PRS through Ambry Genetics, was performed. We found significant associations between higher PRS and younger age of diagnosis (p = 0.002), lower frequency of metastases (p = 0.006), and having a first-degree relative diagnosed with prostate cancer (p = 0.024). We did not observe significant associations between PRS and ISUP GG, histology or a having a second-degree relative with prostate cancer. These findings provide insights into features associated with higher PRS, but larger multi-ancestral studies using PRS that are informative across populations are needed to understand its clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsGenome-Wide Association StudyMultifactorial InheritanceGenetic Predisposition to DiseaseHumansMaleMiddle AgedAgedRetrospective StudiesPolymorphism, Single NucleotideAdultAged, 80 and overRisk AssessmentRisk FactorsNeoplasm GradingGenetic TestingGenetic Risk Score

Stichwörter der Autor:innen

Genetic counselingGenetic testingPolygenic risk scoreProstate cancer

Autor:innen und Institutionen

  • Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University, 2012 Kenny Road, Columbus, OH, 43212, USA. Christina.spears@osumc.edu.
  • Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. Christina.spears@osumc.edu.
  • Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, USA.
  • Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University, 2012 Kenny Road, Columbus, OH, 43212, USA.

ORCID-Profile: Christina Spears, Menglin Xu, Amanda Ewart Toland

Zitieren

APA

Spears, C., Xu, M., Shoben, A., Dason, S., Toland, A. E., & Byrne, L. (2024). Clinical features of prostate cancer by polygenic risk score. Familial Cancer. https://doi.org/10.1007/s10689-024-00369-0

Vancouver

Spears C, Xu M, Shoben A, Dason S, Toland AE, Byrne L. Clinical features of prostate cancer by polygenic risk score. Familial Cancer. 2024. doi:10.1007/s10689-024-00369-0

BibTeX
@article{Spears2024,
  author = {Spears, Christina and Xu, Menglin and Shoben, Abigail and Dason, Shawn and Toland, Amanda Ewart and Byrne, Lindsey},
  title = {Clinical features of prostate cancer by polygenic risk score},
  journal = {Familial Cancer},
  year = {2024},
  doi = {10.1007/s10689-024-00369-0}
}
Kostenlos starten →